Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 895

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 895
---
The accompanying notes are an integral part of these financial statements. F-92

TABLE OF CONTENTS Tvardi Therapeutics, Inc. Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit
(Amounts in thousands, except share amounts)

| ​                                        
 ​                                        | ​ 
 ​ | ​ 
 ​ | RedeemableConvertiblePreferredStock 
 Shares                              |   |            |   | ​ | ​ | Amount |   |        |   | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | CommonStock 
 Shares      |   |            |   | ​ | ​ | Amount |   |    |   | ​ 
 ​ | ​ | AdditionalPaid-InCapital |   |     |   | ​ | ​ | AccumulatedDeficit |   |         |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |     |   | ​ | ​ | TotalStockholders’Deficit |   |         |   | ​ |
|:-----------------------------------------|:--|:--|:------------------------------------|:--|-----------:|:--|:--|:--|:-------|:--|-------:|:--|:--|:--|:--|:------------|:--|-----------:|:--|:--|:--|:-------|:--|---:|:--|:--|:--|:-------------------------|:--|----:|:--|:--|:--|:-------------------|:--|--------:|:--|:--|:--|:----------------------------------|:--|----:|:--|:--|:--|:--------------------------|:--|--------:|:--|:--|
| Balances as of January 1, 2022           | ​ | ​ | ​                                   | ​ | 29,555,538 | ​ | ​ | ​ | ​      | $ | 85,503 | ​ | ​ | ​ | ​ | ​           | ​ | 19,096,873 | ​ | ​ | ​ | ​      | $ | 19 | ​ | ​ | ​ | ​                        | $ | 196 | ​ | ​ | ​ | ​                  | $ | -24,950 | ​ | ​ | ​ | ​                                 | $ |   — | ​ | ​ | ​ | ​                         | $ | -24,735 | ​ | ​ |
| Exercise of stock options                | ​